You are here

  • Home
  • Archive
  • Volume 61, Issue 12
  • Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Article metrics

Article menu
Download PDFPDF
Original articles
Inflammatory bowel disease
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

 

Online download statistics by month:

Online download statistics by month: May 2012 to March 2024

AbstractFullPdf
May 201278399143
Jun 2012351111123
Jul 20122427769
Aug 20122088151
Sep 20121987855
Oct 201222910281
Nov 20122250103206
Dec 201297055112
Jan 2013698102102
Feb 20134197784
Mar 20133235879
Apr 20133007877
May 20132405650
Jun 20131545346
Jul 20132316255
Aug 20131145736
Sep 20132056746
Oct 20131627459
Nov 20131758165
Dec 20131465546
Jan 201415679100
Feb 20141394840
Mar 20141666845
Apr 20141295852
May 20141146339
Jun 20141274243
Jul 20141295741
Aug 201414540088
Sep 20141282433
Oct 20141275446
Nov 20141173638
Dec 20141092927
Jan 20151244946
Feb 20151534447
Mar 20151444857
Apr 20151076154
May 20151473941
Jun 20151236649
Jul 2015943638
Aug 2015984451
Sep 20151245856
Oct 2015983140
Nov 20151655769
Dec 20151822835
Jan 20161885668
Feb 20162348598
Mar 201622112065
Apr 20161948669
May 20161766974
Jun 20161383235
Jul 20161301830
Aug 20161352635
Sep 20161804027
Oct 20162056822
Nov 20162293739
Dec 20161944052
Jan 20172084743
Feb 20172315766
Mar 20172217258
Apr 20171934734
May 201719311061
Jun 20172138843
Jul 20172956035
Aug 20173904833
Sep 20173596860
Oct 20175188954
Nov 20173934932
Dec 20174795525
Jan 20184834522
Feb 20184076227
Mar 20184226832
Apr 20183484731
May 20184716348
Jun 20183134325
Jul 20184144834
Aug 20182594935
Sep 20183415627
Oct 20184004126
Nov 20183614432
Dec 20182934421
Jan 20193634117
Feb 20192445235
Mar 20193728245
Apr 20192583719
May 20193154225
Jun 20192492818
Jul 20192224416
Aug 20193025824
Sep 20192925522
Oct 20192535522
Nov 20192053923
Dec 20193223722
Jan 20202644525
Feb 20202343824
Mar 20203252420
Apr 20202747319
May 20202102813
Jun 20203473031
Jul 20202623023
Aug 20202213224
Sep 20203733932
Oct 20202953324
Nov 20202533318
Dec 20202784030
Jan 20212532613
Feb 20213222921
Mar 20213285032
Apr 202133511018
May 20212004131
Jun 202110610319
Jul 2021333217
Aug 2021353415
Sep 2021585416
Oct 20213033822
Nov 20213834116
Dec 20213533819
Jan 20223364222
Feb 20223956214
Mar 20224663914
Apr 20223576521
May 20223696222
Jun 20222923321
Jul 20224354015
Aug 20224724320
Sep 20224095315
Oct 20223644811
Nov 20224916021
Dec 20225274216
Jan 20235546230
Feb 20233794915
Mar 20235233610
Apr 20233485131
May 20233193519
Jun 20232692913
Jul 20233923019
Aug 2023290217
Sep 20233284719
Oct 20234975121
Nov 20235314113
Dec 20235047315
Jan 20245592716
Feb 20245846936
Mar 20245836333
Total4298780065597